NVAX, GRPN and MVIS Among Mid-day Movers

Seeking AlphaMay 11 00:57

Sensus Healthcare | 10-Q: Quarterly report

Futu NewsMay 11 00:29 · Announcements

Sensus Healthcare Is Maintained at Buy by Maxim Group

Sensus Healthcare Is Maintained at Buy by Maxim Group

Dow JonesMay 10 23:19

Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.

Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.

Zhitong FinanceMay 10 23:10

Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10

Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $7 to $10.

BenzingaMay 10 23:09

Sensus Healthcare Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 115.99% Maxim Group $7 → $10 Maintains Buy 11/13/2023 72.79% HC Wainwright & Co. → $8 Reiterate

BenzingaMay 10 23:07